AstraZeneca Net Worth 2006-2019 | AZN

Interactive chart of historical net worth (market cap) for AstraZeneca (AZN) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AstraZeneca net worth as of July 12, 2019 is $101.85B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $101.848B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $356.574B 16.34
Pfizer (PFE) United States $235.741B 13.77
Roche Holding AG (RHHBY) Switzerland $227.825B 0.00
Merck (MRK) United States $205.276B 17.68
Novartis AG (NVS) Switzerland $202.334B 17.60
Novo Nordisk (NVO) Denmark $116.467B 19.33
Eli Lilly (LLY) United States $105.131B 19.51
AbbVie (ABBV) United States $103.897B 8.59
Sanofi (SNY) France $103.048B 12.70
GlaxoSmithKline (GSK) United Kingdom $100.266B 12.71
Bristol-Myers Squibb (BMY) United States $72.413B 10.69
Bayer Aktiengesellschaft (BAYRY) Germany $61.955B 9.03
H Lundbeck (HLUYY) Denmark $7.627B 11.01